Nicotine vaccines for smoking cessation

Pharmacology, Toxicology and Pharmaceutical Science

• Nicotine Vaccine 100%
• Vaccine 47%
• Adverse Event 42%
• Placebo 26%
• Nicotine 15%
• Relapse 15%
• Blindness 5%
• Drug Development 5%
• Tolerability 5%
• Antibody 5%
• Randomized Controlled Trial 5%
• Tobacco Dependence 5%
• Withdrawal Syndrome 5%
• Smoke 5%
• Flu Like Syndrome 5%